Skip to content

Anti-Obesity Drug Linked to Depression

November 19, 2007

A new study published in The Lancet suggests the anti-obesity medication rimonabant (Acomplia) can double the risk of anxiety and depression. Researchers analyzing 4 studies involving over 4,000 patients found those taking 20 milligrams of the drug daily were 2.5 times more likely to stop treatment due to depressive disorders, and 3 times more likely to stop because of anxiety compared to those who were administered a placebo.

One Comment leave one →
  1. November 19, 2007 7:58 pm

    I wonder: did the people taking the placebo also lose weight?

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: